Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1990;17(1):31–36.

Coronary Angioplasty in Emergency Treatment of Myocardial Infarction in a Community-Hospital Setting

Rodolfo P Sotolongo 1,2,3, Michael L Smith 1,2,3, Wayne S Margolis 1,2,3
PMCID: PMC324897  PMID: 15227186

Abstract

From July 1986 through June 1988, 135 consecutive patients with myocardial infarction, including 23 in cardiogenic shock, were treated with percutaneous transluminal coronary angioplasty in a community-hospital setting. In 109 (81%) of the cases, angioplasty was successful, resulting in brisk anterograde flow and in residual stenosis of less than 50%. The success rate was 88% (99/112) for patients not in cardiogenic shock and 43% (10/23) for those in shock. During the term of hospitalization, clinically evident total reocclusion occurred in 5 (4%) patients not in shock on presentation (2 of these experienced anterior infarction, and 3 inferior infarction); repeat angioplasty was performed successfully in all 5. No clinical reocclusion was detected in the smaller group of patients admitted in shock.

Eleven patients (8%) underwent emergency coronary artery bypass grafting following the coronary angioplasty procedure: 4 for failed angioplasty in the infarct-related artery, and the other 7 for severe triple-vessel disease.

Hospital mortality was 0.9% (1/112) for patients not in cardiogenic shock and 52% (12/23) for those admitted in shock, for an overall rate of 10% (13/135). Among patients whose balloon angioplasty was successful, hospital mortality was 0% for those not in shock and 30% (3/10) for those in shock. Among patients whose angioplasty failed, however, mortality was 8% (1/13) for those not in shock and 69% (9/13) for those admitted in shock. (Texas Heart Institute Journal 1990;17:31-6)

Keywords: Angioplasty, transluminal

Keywords: coronary thrombosis

Keywords: fibrinolysis

Keywords: myocardial infarction

Keywords: shock, cardiogenic

Full text

PDF
31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DeWood M. A., Notske R. N., Hensley G. R., Shields J. P., O'Grady W. P., Spores J., Goldman M., Ganji J. H. Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation. 1980 Jun;61(6):1105–1112. doi: 10.1161/01.cir.61.6.1105. [DOI] [PubMed] [Google Scholar]
  2. DeWood M. A., Spores J., Notske R., Mouser L. T., Burroughs R., Golden M. S., Lang H. T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980 Oct 16;303(16):897–902. doi: 10.1056/NEJM198010163031601. [DOI] [PubMed] [Google Scholar]
  3. Fung A. Y., Lai P., Topol E. J., Bates E. R., Bourdillon P. D., Walton J. A., Mancini G. B., Kryski T., Pitt B., O'Neill W. W. Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction. Am J Cardiol. 1986 Oct 1;58(9):686–691. doi: 10.1016/0002-9149(86)90338-3. [DOI] [PubMed] [Google Scholar]
  4. Gold H. K., Leinbach R. C., Garabedian H. D., Yasuda T., Johns J. A., Grossbard E. B., Palacios I., Collen D. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation. 1986 Feb;73(2):347–352. doi: 10.1161/01.cir.73.2.347. [DOI] [PubMed] [Google Scholar]
  5. Harrison D. G., Ferguson D. W., Collins S. M., Skorton D. J., Ericksen E. E., Kioschos J. M., Marcus M. L., White C. W. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation. 1984 May;69(5):991–999. doi: 10.1161/01.cir.69.5.991. [DOI] [PubMed] [Google Scholar]
  6. Hartzler G. O., Rutherford B. D., McConahay D. R., Johnson W. L., Jr, McCallister B. D., Gura G. M., Jr, Conn R. C., Crockett J. E. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J. 1983 Nov;106(5 Pt 1):965–973. doi: 10.1016/0002-8703(83)90639-7. [DOI] [PubMed] [Google Scholar]
  7. Hillis L. D., Borer J., Braunwald E., Chesebro J. H., Cohen L. S., Dalen J., Dodge H. T., Francis C. K., Knatterud G., Ludbrook P. High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial. J Am Coll Cardiol. 1985 Nov;6(5):957–962. doi: 10.1016/s0735-1097(85)80294-1. [DOI] [PubMed] [Google Scholar]
  8. Kennedy J. W., Gensini G. G., Timmis G. C., Maynard C. Acute myocardial infarction treated with intracoronary streptokinase: a report of the Society for Cardiac Angiography. Am J Cardiol. 1985 Apr 1;55(8):871–877. doi: 10.1016/0002-9149(85)90709-x. [DOI] [PubMed] [Google Scholar]
  9. Meyer J., Merx W., Schmitz H., Erbel R., Kiesslich T., Dörr R., Lambertz H., Bethge C., Krebs W., Bardos P. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation. 1982 Nov;66(5):905–913. doi: 10.1161/01.cir.66.5.905. [DOI] [PubMed] [Google Scholar]
  10. Mirowski M., Israel W., Antonopoulos A. G., Mower M. M., Mendeloff A. I. Treatment of myocardial infarction in a community hospital coronary care unit. Experience with 1,246 patients. Arch Intern Med. 1978 Feb;138(2):210–215. [PubMed] [Google Scholar]
  11. O'Neill W., Timmis G. C., Bourdillon P. D., Lai P., Ganghadarhan V., Walton J., Jr, Ramos R., Laufer N., Gordon S., Schork M. A. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med. 1986 Mar 27;314(13):812–818. doi: 10.1056/NEJM198603273141303. [DOI] [PubMed] [Google Scholar]
  12. Papapietro S. E., MacLean W. A., Stanley A. W., Jr, Hess R. G., Corley N., Arciniegas J. G., Cooper T. B. Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction. Am J Cardiol. 1985 Jan 1;55(1):48–53. doi: 10.1016/0002-9149(85)90297-8. [DOI] [PubMed] [Google Scholar]
  13. Rackley C. E., Russell R. O., Jr, Mantle J. A., Moraski R. E. Cardiogenic shock: recognition and management. Cardiovasc Clin. 1975;7(2):251–258. [PubMed] [Google Scholar]
  14. Scheidt S., Wilner G., Mueller H., Summers D., Lesch M., Wolff G., Krakauer J., Rubenfire M., Fleming P., Noon G. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med. 1973 May 10;288(19):979–984. doi: 10.1056/NEJM197305102881901. [DOI] [PubMed] [Google Scholar]
  15. Serruys P. W., Wijns W., van den Brand M., Ribeiro V., Fioretti P., Simoons M. L., Kooijman C. J., Reiber J. H., Hugenholtz P. G. Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study. Br Heart J. 1983 Sep;50(3):257–265. doi: 10.1136/hrt.50.3.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Simoons M. L., Serruys P. W., van den Brand M., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Bär F., de Zwaan C., van der Laarse A. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol. 1986 Apr;7(4):717–728. doi: 10.1016/s0735-1097(86)80329-1. [DOI] [PubMed] [Google Scholar]
  17. Stack R. S., Califf R. M., Hinohara T., Phillips H. R., Pryor D. B., Simonton C. A., Carlson E. B., Morris K. G., Behar V. S., Kong Y. Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1988 Jun;11(6):1141–1149. doi: 10.1016/0735-1097(88)90274-4. [DOI] [PubMed] [Google Scholar]
  18. Stack R. S., O'Connor C. M., Mark D. B., Hinohara T., Phillips H. R., Lee M. M., Ramirez N. M., O'Callaghan W. G., Simonton C. A., Carlson E. B. Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase. Circulation. 1988 Jan;77(1):151–161. doi: 10.1161/01.cir.77.1.151. [DOI] [PubMed] [Google Scholar]
  19. Topol E. J., Eha J. E., Brin K. P., Shapiro E. P., Weiss J. L., Riegel M. B., Gottlieb S. O., Brinker J. A. Applicability of percutaneous transluminal coronary angioplasty to patients with recombinant tissue plasminogen activator mediated thrombolysis. Cathet Cardiovasc Diagn. 1985;11(4):337–348. doi: 10.1002/ccd.1810110402. [DOI] [PubMed] [Google Scholar]
  20. Topol E. J., O'Neill W. W., Langburd A. B., Walton J. A., Jr, Bourdillon P. D., Bates E. R., Grines C. L., Schork A. M., Kline E., Pitt B. A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation. 1987 Feb;75(2):420–428. doi: 10.1161/01.cir.75.2.420. [DOI] [PubMed] [Google Scholar]
  21. Topol E. J., Weiss J. L., Brinker J. A., Brin K. P., Gottlieb S. O., Becker L. C., Bulkley B. H., Chandra N., Flaherty J. T., Gerstenblith G. Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: importance of coronary angioplasty. J Am Coll Cardiol. 1985 Aug;6(2):426–433. doi: 10.1016/s0735-1097(85)80182-0. [DOI] [PubMed] [Google Scholar]
  22. Verstraete M., Bernard R., Bory M., Brower R. W., Collen D., de Bono D. P., Erbel R., Huhmann W., Lennane R. J., Lubsen J. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985 Apr 13;1(8433):842–847. doi: 10.1016/s0140-6736(85)92208-1. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES